1[1]Quyyumi AA, Diodati JG, LaKaatos E, et al. Angiogenie effects of LMWH in patients loith stable coronary disease: A Apilot study[J]. J Am Coll Cardiol, 1993,22:635-637.
2[2]Berkowitz SD, Stinnet S, Cohen M, et al. Prospective comparison of hemorrhagic complication after treatment with enoxaparin versus ummctionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction[J]. Am J Cardiol, 2001,88:1230-1234.
3[3]Johathab Abrams MD. Medical therapy of unstable angina and non-Q-wave myocaridial infarction[J]. Am J Cardial, 2000,86: 24-32.
5[5]Fareed J, Hoppensteadt DA. Pharmacology of low moiecular weight heparins [ J ]. Semin Thromb Hemost, 1996,22(sppl) :13-18.
6[6]Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts[J]. J Clin Invest,1994,94:623-630.
7[7]Banai S, Jaklitsch MT, Show M, et al. Angiogenic-induce enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factorinin in dogs. Circulation, 1994,89:2183-2193.
